170 related articles for article (PubMed ID: 11214119)
1. World trade rules and cheaper drugs.
Lancet; 2001 Jan; 357(9252):243. PubMed ID: 11214119
[No Abstract] [Full Text] [Related]
2. The role of civil society in protecting public health over commercial interests: lessons from Thailand.
Ford N; Wilson D; Bunjumnong O; von Schoen Angerer T
Lancet; 2004 Feb; 363(9408):560-3. PubMed ID: 14975620
[No Abstract] [Full Text] [Related]
3. Canada to change patent law to allow export of cheap drugs.
Kondro W
Lancet; 2003 Oct; 362(9392):1290. PubMed ID: 14577437
[No Abstract] [Full Text] [Related]
4. Patent necessity: intellectual property dilemmas in the biotech domain and treatment equity for developing countries.
Spectar JM
Houst J Int Law; 2002; 24(2):227-78. PubMed ID: 16189914
[No Abstract] [Full Text] [Related]
5. Drug firms lose patent rights lawsuit against South Africa's government.
Baleta A
Lancet; 2001 Apr; 357(9265):1347. PubMed ID: 11343755
[No Abstract] [Full Text] [Related]
6. The WTO dispute settlement understanding: an unlikely weapon in the fight against AIDS.
Curti AM
Am J Law Med; 2001; 27(4):469-85. PubMed ID: 11837145
[No Abstract] [Full Text] [Related]
7. Gore under fire in controversy over South Africa AIDS drug law.
Wadman M
Nature; 1999 Jun; 399(6738):717-8. PubMed ID: 10391225
[No Abstract] [Full Text] [Related]
8. Brazil's AIDS controversy: antiretroviral drugs, breaking patents, and compulsory licensing.
Marques UR; Guimarães VS; Sternberg C
Food Drug Law J; 2005; 60(3):471-7. PubMed ID: 16304752
[No Abstract] [Full Text] [Related]
9. Access to treatment for HIV/AIDS: a human rights issue in the developing world.
Joni J
Conn J Int Law; 2002; 17(2):273-80. PubMed ID: 12688296
[No Abstract] [Full Text] [Related]
10. No money, no meds.
Mabry M
Newsweek; 1999 Jul; 134(2):32-3. PubMed ID: 10538648
[No Abstract] [Full Text] [Related]
11. [The patent legislation in India fails the HIV/AIDS work].
Holen Ø
Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2666-7. PubMed ID: 16215618
[No Abstract] [Full Text] [Related]
12. Next steps against AIDS.
Nature; 2001 Apr; 410(6832):1009. PubMed ID: 11323620
[No Abstract] [Full Text] [Related]
13. GSK and Boehringer agree to generic AIDS drugs deal.
Nelson K
Lancet; 2003 Dec; 362(9401):2074. PubMed ID: 14700066
[No Abstract] [Full Text] [Related]
14. Medicines for all, not just the rich.
Davey S
Bull World Health Organ; 2001; 79(4):377-8. PubMed ID: 11357220
[No Abstract] [Full Text] [Related]
15. TRIPS AGREEMENT ARTICLE 31(B): THE NEED FOR REVISION.
Effingham AM
Seton Hall Law Rev; 2016; 46(3):883-909. PubMed ID: 27066613
[No Abstract] [Full Text] [Related]
16. Public health. HIV/AIDS treatment for millions.
Binswanger HP
Science; 2001 Apr; 292(5515):221-3. PubMed ID: 11305311
[No Abstract] [Full Text] [Related]
17. HIV/AIDS: Latin America & Caribbean. Brazil: ten years after.
Cohen J
Science; 2006 Jul; 313(5786):484-7. PubMed ID: 16873654
[No Abstract] [Full Text] [Related]
18. Should the patent system for new medicines be abolished?
DiMasi JA; Grabowski HG
Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100
[No Abstract] [Full Text] [Related]
19. South Africa may keep door closed to generic AIDS drugs.
Cherry M
Nature; 2001 Apr; 410(6832):1013. PubMed ID: 11323627
[No Abstract] [Full Text] [Related]
20. Just the medicine. Cheaper AIDS drugs.
Whitelaw K
US News World Rep; 2001 Mar; 130(12):31. PubMed ID: 11277041
[No Abstract] [Full Text] [Related]
[Next] [New Search]
